Header Logo
Last Name


TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kaur M, Dalal RL, Shaffer S, Schwartz DA, Rubin DT. Inpatient Management of Inflammatory Bowel Disease-Related Complications. Clin Gastroenterol Hepatol. 2020 May; 18(6):1346-1355. PMID: 31927105.
      View in: PubMed
    2. Larson ED, Magno JPM, Steritz MJ, Llanes EGDV, Cardwell J, Pedro M, Roberts TB, Einarsdottir E, Rosanes RAQ, Greenlee C, Santos RAP, Yousaf A, Streubel SO, Santos ATR, Ruiz AG, Lagrana-Villagracia SM, Ray D, Yarza TKL, Scholes MA, Anderson CB, Acharya A, Gubbels SP, Bamshad MJ, Cass SP, Lee NR, Shaikh RS, Nickerson DA, Mohlke KL, Prager JD, Cruz TLG, Yoon PJ, Abes GT, Schwartz DA, Chan AL, Wine TM, Cutiongco-de la Paz EM, Friedman N, Kechris K, Kere J, Leal SM, Yang IV, Patel JA, Tantoco MLC, Riazuddin S, Chan KH, Mattila PS, Reyes-Quintos MRT, Ahmed ZM, Jenkins HA, Chonmaitree T, Hafrén L, Chiong CM, Santos-Cortez RLP. A2ML1 and otitis media: novel variants, differential expression, and relevant pathways. Hum Mutat. 2019 08; 40(8):1156-1171. PMID: 31009165.
      View in: PubMed
    3. Musunuru K, Bernstein D, Cole FS, Khokha MK, Lee FS, Lin S, McDonald TV, Moskowitz IP, Quertermous T, Sankaran VG, Schwartz DA, Silverman EK, Zhou X, Hasan AAK, Luo XJ. Functional Assays to Screen and Dissect Genomic Hits: Doubling Down on the National Investment in Genomic Research. Circ Genom Precis Med. 2018 04; 11(4):e002178. PMID: 29654098.
      View in: PubMed
    4. Harris KA, Horst S, Gadani A, Nohl A, Annis K, Duley C, Beaulieu D, Ghazi L, Schwartz DA. Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab. Inflamm Bowel Dis. 2016 Feb; 22(2):397-401. PMID: 26752468.
      View in: PubMed
    5. Wasserman R, Anderson BJ, Schwartz DD. Illness-specific risk-taking in adolescence: A missing piece of the nonadherence puzzle for youth with type 1 diabetes?. Diabetes Spectr. 2016.
    6. Schwartz DD, Axelrad ME. SpringerBriefs in Child Health. Healthcare partnerships for pediatric adherence: promoting collaborative management for pediatric chronic illness care. 2015.
    7. Horst S, Chao A, Rosen M, Nohl A, Duley C, Wagnon JH, Beaulieu DB, Taylor W, Gaines L, Schwartz DA. Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease. Dig Dis Sci. 2015 Feb; 60(2):465-70. PMID: 25274158.
      View in: PubMed
    8. Schwartz DD, Wasserman R, Powell PW, Axelrad ME. Neurocognitive outcomes in pediatric diabetes: a developmental perspective. Curr Diab Rep. 2014 Oct; 14(10):533. PMID: 25142718.
      View in: PubMed
    9. Schwartz DD, Axelrad ME, Anderson BJ. Neurocognitive functioning in children and adolescents at the time of type 1 diabetes diagnosis: associations with glycemic control 1 year after diagnosis. Diabetes Care. 2014 Sep; 37(9):2475-82. PMID: 24969580.
      View in: PubMed
    10. Falaiye TO, Mitchell KR, Lu Z, Saville BR, Horst SN, Moulton DE, Schwartz DA, Wilson KT, Rosen MJ. Outcomes following infliximab therapy for pediatric patients hospitalized with refractory colitis-predominant IBD. J Pediatr Gastroenterol Nutr. 2014 Feb; 58(2):213-9. PMID: 24048170.
      View in: PubMed
    11. Schwartz DD, Katzenstein JM, Hopkins E, Stabley DL, Sol-Church K, Gripp KW, Axelrad ME. Verbal memory functioning in adolescents and young adults with Costello syndrome: evidence for relative preservation in recognition memory. Am J Med Genet A. 2013 Sep; 161A(9):2258-65. PMID: 23918324.
      View in: PubMed
    12. Grisaru-Soen G, Eisenstadt M, Paret G, Schwartz D, Keller N, Nagar H, Reif S. Pediatric parapneumonic empyema: risk factors, clinical characteristics, microbiology, and management. Pediatr Emerg Care. 2013 Apr; 29(4):425-9. PMID: 23528501.
      View in: PubMed
    13. Treble A, Chapman SG, Schwartz DD, Axelrad ME. Brief behavioral intervention for disruptive behavior in a child following frontal and temporal resection for medically intractable epilepsy: A case report. Clinical Practice in Pediatric Psychology. 2013; 1:355-360.
    14. Schwartz DD, Axelrad ME, Anderson BJ. Psychosocial risk screening of children newly diagnosed with type 1 diabetes: a training toolkit for healthcare professionals. 2013.
    15. Schwartz DD, Cline VD, Axelrad ME, Anderson BJ. Feasibility, acceptability, and predictive validity of a psychosocial screening program for children and youth newly diagnosed with type 1 diabetes. Diabetes Care. 2011 Feb; 34(2):326-31. PMID: 21216856.
      View in: PubMed
    16. Schwartz DD, Axelrad ME, Cline VD, Anderson BJ. A model psychosocial screening program for children and youth with newly diagnosed type 1 diabetes: Implications for psychologists across contexts of care. Professional Psychology: Research and Practice. 2011; (42):324-330.
    17. Schwartz DD, Cline VD, Hansen JA, Axelrad ME, Anderson BJ. Early risk factors for nonadherence in pediatric type 1 diabetes: a review of the recent literature. Curr Diabetes Rev. 2010 May; 6(3):167-83. PMID: 20380630.
      View in: PubMed
    18. Goldman M, Rosenfeld-Yehoshua N, Lerner-Geva L, Lazarovitch T, Schwartz D, Grisaru-Soen G. Clinical features of community-acquired Pseudomonas aeruginosa urinary tract infections in children. Pediatr Nephrol. 2008 May; 23(5):765-8. PMID: 18299898.
      View in: PubMed
    SCHWARTZ's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description